Global Acne Treatment Market Size Study & Forecast, by Product (Retinoids, Antibiotics, Isotretinoin, Others), by Route of Administration (Oral, Topical), by Age Group (10 to 17 Years, 18 to 44 Years, 45 to 64 Years, 65 Years & Above), by Distribution Channel (Hospital Pharmacies, Retail & Online Pharmacies), and Regional Analysis, 2023-2030
Global Acne Treatment Market is valued at approximately USD 10.48 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 5.1% over the forecast period 2023-2030. Acne treatment refers to a variety of methods, therapies, and products that are specilly developed to manage and alleviate the acne symptoms. Acne is a skin condition that develops when oil and dead skin cells block hair follicles. It is commonly characterized by the presence of pimples, blackheads, whiteheads, and in some cases, more severe forms such as cysts and nodules. The rising prevalence of acne among the population, rising demand for aesthetic procedures, coupled with the growing awareness about skincare and the availability of treatments are the most prominent factors that are propelling the market demand across the world. As per the National Center for Biotechnology Information (NCBI), it was estimated that the prevalence of acne affected 9.4% of the worldwide population in 2022, accordingly, which is recorded as the eighth most prevalent disease globally.
In addition, the growing clinical approval of drugs is exhibiting a positive influence on market growth. Clinical approval reflects the ongoing efforts in the pharmaceutical and dermatological industries to develop effective and safe solutions for managing this common skin condition. For instance, Alembic Pharmaceuticals' topical retinoid adapalene gel USP 0.3% has received approval from the U.S. Food and Drug Administration (FDA) to be used to treat acne vulgaris. Similarly, in June 2022, Zydus Lifesciences obtained FDA permission to commercialize Adapalene with Benzoyl Peroxide topical gel in the United States. This generic drug is used to treat acne. Moreover, the growing trend of customized treatment approaches, as well as the increase in medical tourism for dermatological procedures presents various lucrative opportunities over the forecast years. However, the side effects of acne treatments and the stringent regulatory standards are hindering the market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Acne Treatment Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the growing concerns related to beauty among the population, increasing awareness regarding advanced treatments, and strong investment in R&D for the drugs used for the treatment of dermatology conditions. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecast years. The increasing prevalence of acne, the introduction of new and improved acne treatment options, as well as surging demand for aesthetic treatments, are significantly propelling the market demand across the region.
Major market players included in this report are:
ABBVIE INC. (Ireland)
Botanix Pharmaceuticals (Australia)
GALDERMA (Switzerland)
Bausch Health Companies Inc. (U.S.)
GlaxoSmithKline Plc. (U.K.)
Bayer AG (Germany)
Johnson & Johnson Services, Inc. (U.S.)
Pfizer Inc. (U.S.)
Teva Pharmaceutical Industries Ltd. (Israel)
Sun Pharmaceutical Industries Ltd. (India)
Recent Developments in the Market:
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Retinoids
Antibiotics
Isotretinoin
Others
By Route of Administration:
Oral
Topical
By Age Group:
10 to 17 Years
18 to 44 Years
45 to 64 Years
65 Years & Above
By Distribution Channel:
Hospital Pharmacies
Retail & Online Pharmacies
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
In addition, the growing clinical approval of drugs is exhibiting a positive influence on market growth. Clinical approval reflects the ongoing efforts in the pharmaceutical and dermatological industries to develop effective and safe solutions for managing this common skin condition. For instance, Alembic Pharmaceuticals' topical retinoid adapalene gel USP 0.3% has received approval from the U.S. Food and Drug Administration (FDA) to be used to treat acne vulgaris. Similarly, in June 2022, Zydus Lifesciences obtained FDA permission to commercialize Adapalene with Benzoyl Peroxide topical gel in the United States. This generic drug is used to treat acne. Moreover, the growing trend of customized treatment approaches, as well as the increase in medical tourism for dermatological procedures presents various lucrative opportunities over the forecast years. However, the side effects of acne treatments and the stringent regulatory standards are hindering the market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Acne Treatment Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the growing concerns related to beauty among the population, increasing awareness regarding advanced treatments, and strong investment in R&D for the drugs used for the treatment of dermatology conditions. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecast years. The increasing prevalence of acne, the introduction of new and improved acne treatment options, as well as surging demand for aesthetic treatments, are significantly propelling the market demand across the region.
Major market players included in this report are:
ABBVIE INC. (Ireland)
Botanix Pharmaceuticals (Australia)
GALDERMA (Switzerland)
Bausch Health Companies Inc. (U.S.)
GlaxoSmithKline Plc. (U.K.)
Bayer AG (Germany)
Johnson & Johnson Services, Inc. (U.S.)
Pfizer Inc. (U.S.)
Teva Pharmaceutical Industries Ltd. (Israel)
Sun Pharmaceutical Industries Ltd. (India)
Recent Developments in the Market:
- In December 2022, Beiersdorf AG announced the acquisition of S-Biomedic NV, a business in Belgium to strengthen its expertise in the market.
- In September 2021, Mayne Pharma Group Limited unveiled the introduction of 10 mg, 20 mg, 30 mg, and 40 mg isotretinoin capsules. These capsules, now available in the U.S., offer a generic alternative to ABSORICA. They are specifically designed to address severe recalcitrant nodular acne, providing patients with an effective treatment option.
- Historical Data – 2020 - 2021
- Base Year for Estimation – 2022
- Forecast period - 2023-2030
- Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
- Segments Covered - Product, Route of Administration, Age Group, Distribution Channel, Region
- Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
- Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Retinoids
Antibiotics
Isotretinoin
Others
By Route of Administration:
Oral
Topical
By Age Group:
10 to 17 Years
18 to 44 Years
45 to 64 Years
65 Years & Above
By Distribution Channel:
Hospital Pharmacies
Retail & Online Pharmacies
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Acne Treatment Market, by Region, 2020-2030 (USD Billion)
1.2.2. Acne Treatment Market, by Product, 2020-2030 (USD Billion)
1.2.3. Acne Treatment Market, by Route of Administration, 2020-2030 (USD Billion)
1.2.4. Acne Treatment Market, by Age Group, 2020-2030 (USD Billion)
1.2.5. Acne Treatment Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL ACNE TREATMENT MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL ACNE TREATMENT MARKET DYNAMICS
3.1. Acne Treatment Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Rising prevalence of acne among the population
3.1.1.2. Growing clinical approval of drugs
3.1.2. Market Challenges
3.1.2.1. Side effects of acne treatments
3.1.2.2. Stringent regulatory standards
3.1.3. Market Opportunities
3.1.3.1. Growing trend of customized treatment approaches
3.1.3.2. Increase in medical tourism for dermatological procedures
CHAPTER 4. GLOBAL ACNE TREATMENT MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL ACNE TREATMENT MARKET, BY PRODUCT
5.1. Market Snapshot
5.2. Global Acne Treatment Market by Product, Performance - Potential Analysis
5.3. Global Acne Treatment Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
5.4. Acne Treatment Market, Sub Segment Analysis
5.4.1. Retinoids
5.4.2. Antibiotics
5.4.3. Isotretinoin
5.4.4. Others
CHAPTER 6. GLOBAL ACNE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION
6.1. Market Snapshot
6.2. Global Acne Treatment Market by Route of Administration, Performance - Potential Analysis
6.3. Global Acne Treatment Market Estimates & Forecasts by Route of Administration 2020-2030 (USD Billion)
6.4. Acne Treatment Market, Sub Segment Analysis
6.4.1. Oral
6.4.2. Topical
CHAPTER 7. GLOBAL ACNE TREATMENT MARKET, BY AGE GROUP
7.1. Market Snapshot
7.2. Global Acne Treatment Market by Age Group, Performance - Potential Analysis
7.3. Global Acne Treatment Market Estimates & Forecasts by Age Group 2020-2030 (USD Billion)
7.4. Acne Treatment Market, Sub Segment Analysis
7.4.1. 10 to 17 Years
7.4.2. 18 to 44 Years
7.4.3. 45 to 64 Years
7.4.4. 65 Years & Above
CHAPTER 8. ACNE TREATMENT MARKET, BY DISTRIBUTION CHANNEL
8.1. Market Snapshot
8.2. Global Acne Treatment Market by Distribution Channel, Performance - Potential Analysis
8.3. Global Acne Treatment Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
8.4. Acne Treatment Market, Sub Segment Analysis
8.4.1. Hospital Pharmacies
8.4.2. Retail & Online Pharmacies
CHAPTER 9. GLOBAL ACNE TREATMENT MARKET, REGIONAL ANALYSIS
9.1. Top Leading Countries
9.2. Top Emerging Countries
9.3. Acne Treatment Market, Regional Market Snapshot
9.4. North America Acne Treatment Market
9.4.1. U.S. Acne Treatment Market
9.4.1.1. Product breakdown estimates & forecasts, 2020-2030
9.4.1.2. Route of Administration breakdown estimates & forecasts, 2020-2030
9.4.1.3. Age Group breakdown estimates & forecasts, 2020-2030
9.4.1.4. Distribution Channel breakdown estimates & forecasts, 2020-2030
9.4.2. Canada Acne Treatment Market
9.5. Europe Acne Treatment Market Snapshot
9.5.1. U.K. Acne Treatment Market
9.5.2. Germany Acne Treatment Market
9.5.3. France Acne Treatment Market
9.5.4. Spain Acne Treatment Market
9.5.5. Italy Acne Treatment Market
9.5.6. Rest of Europe Acne Treatment Market
9.6. Asia-Pacific Acne Treatment Market Snapshot
9.6.1. China Acne Treatment Market
9.6.2. India Acne Treatment Market
9.6.3. Japan Acne Treatment Market
9.6.4. Australia Acne Treatment Market
9.6.5. South Korea Acne Treatment Market
9.6.6. Rest of Asia Pacific Acne Treatment Market
9.7. Latin America Acne Treatment Market Snapshot
9.7.1. Brazil Acne Treatment Market
9.7.2. Mexico Acne Treatment Market
9.8. Middle East & Africa Acne Treatment Market
9.8.1. Saudi Arabia Acne Treatment Market
9.8.2. South Africa Acne Treatment Market
9.8.3. Rest of Middle East & Africa Acne Treatment Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Key Company SWOT Analysis
10.1.1. Company
10.1.2. Company
10.1.3. Company
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. ABBVIE INC. (Ireland)
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Recent Developments
10.3.2. Botanix Pharmaceuticals (Australia)
10.3.3. GALDERMA (Switzerland)
10.3.4. Bausch Health Companies Inc. (U.S.)
10.3.5. GlaxoSmithKline Plc. (U.K.)
10.3.6. Bayer AG (Germany)
10.3.7. Johnson & Johnson Services, Inc. (U.S.)
10.3.8. Pfizer Inc. (U.S.)
10.3.9. Teva Pharmaceutical Industries Ltd. (Israel)
10.3.10. Sun Pharmaceutical Industries Ltd. (India)
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Acne Treatment Market, by Region, 2020-2030 (USD Billion)
1.2.2. Acne Treatment Market, by Product, 2020-2030 (USD Billion)
1.2.3. Acne Treatment Market, by Route of Administration, 2020-2030 (USD Billion)
1.2.4. Acne Treatment Market, by Age Group, 2020-2030 (USD Billion)
1.2.5. Acne Treatment Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL ACNE TREATMENT MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL ACNE TREATMENT MARKET DYNAMICS
3.1. Acne Treatment Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Rising prevalence of acne among the population
3.1.1.2. Growing clinical approval of drugs
3.1.2. Market Challenges
3.1.2.1. Side effects of acne treatments
3.1.2.2. Stringent regulatory standards
3.1.3. Market Opportunities
3.1.3.1. Growing trend of customized treatment approaches
3.1.3.2. Increase in medical tourism for dermatological procedures
CHAPTER 4. GLOBAL ACNE TREATMENT MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL ACNE TREATMENT MARKET, BY PRODUCT
5.1. Market Snapshot
5.2. Global Acne Treatment Market by Product, Performance - Potential Analysis
5.3. Global Acne Treatment Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
5.4. Acne Treatment Market, Sub Segment Analysis
5.4.1. Retinoids
5.4.2. Antibiotics
5.4.3. Isotretinoin
5.4.4. Others
CHAPTER 6. GLOBAL ACNE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION
6.1. Market Snapshot
6.2. Global Acne Treatment Market by Route of Administration, Performance - Potential Analysis
6.3. Global Acne Treatment Market Estimates & Forecasts by Route of Administration 2020-2030 (USD Billion)
6.4. Acne Treatment Market, Sub Segment Analysis
6.4.1. Oral
6.4.2. Topical
CHAPTER 7. GLOBAL ACNE TREATMENT MARKET, BY AGE GROUP
7.1. Market Snapshot
7.2. Global Acne Treatment Market by Age Group, Performance - Potential Analysis
7.3. Global Acne Treatment Market Estimates & Forecasts by Age Group 2020-2030 (USD Billion)
7.4. Acne Treatment Market, Sub Segment Analysis
7.4.1. 10 to 17 Years
7.4.2. 18 to 44 Years
7.4.3. 45 to 64 Years
7.4.4. 65 Years & Above
CHAPTER 8. ACNE TREATMENT MARKET, BY DISTRIBUTION CHANNEL
8.1. Market Snapshot
8.2. Global Acne Treatment Market by Distribution Channel, Performance - Potential Analysis
8.3. Global Acne Treatment Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
8.4. Acne Treatment Market, Sub Segment Analysis
8.4.1. Hospital Pharmacies
8.4.2. Retail & Online Pharmacies
CHAPTER 9. GLOBAL ACNE TREATMENT MARKET, REGIONAL ANALYSIS
9.1. Top Leading Countries
9.2. Top Emerging Countries
9.3. Acne Treatment Market, Regional Market Snapshot
9.4. North America Acne Treatment Market
9.4.1. U.S. Acne Treatment Market
9.4.1.1. Product breakdown estimates & forecasts, 2020-2030
9.4.1.2. Route of Administration breakdown estimates & forecasts, 2020-2030
9.4.1.3. Age Group breakdown estimates & forecasts, 2020-2030
9.4.1.4. Distribution Channel breakdown estimates & forecasts, 2020-2030
9.4.2. Canada Acne Treatment Market
9.5. Europe Acne Treatment Market Snapshot
9.5.1. U.K. Acne Treatment Market
9.5.2. Germany Acne Treatment Market
9.5.3. France Acne Treatment Market
9.5.4. Spain Acne Treatment Market
9.5.5. Italy Acne Treatment Market
9.5.6. Rest of Europe Acne Treatment Market
9.6. Asia-Pacific Acne Treatment Market Snapshot
9.6.1. China Acne Treatment Market
9.6.2. India Acne Treatment Market
9.6.3. Japan Acne Treatment Market
9.6.4. Australia Acne Treatment Market
9.6.5. South Korea Acne Treatment Market
9.6.6. Rest of Asia Pacific Acne Treatment Market
9.7. Latin America Acne Treatment Market Snapshot
9.7.1. Brazil Acne Treatment Market
9.7.2. Mexico Acne Treatment Market
9.8. Middle East & Africa Acne Treatment Market
9.8.1. Saudi Arabia Acne Treatment Market
9.8.2. South Africa Acne Treatment Market
9.8.3. Rest of Middle East & Africa Acne Treatment Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Key Company SWOT Analysis
10.1.1. Company
10.1.2. Company
10.1.3. Company
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. ABBVIE INC. (Ireland)
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Recent Developments
10.3.2. Botanix Pharmaceuticals (Australia)
10.3.3. GALDERMA (Switzerland)
10.3.4. Bausch Health Companies Inc. (U.S.)
10.3.5. GlaxoSmithKline Plc. (U.K.)
10.3.6. Bayer AG (Germany)
10.3.7. Johnson & Johnson Services, Inc. (U.S.)
10.3.8. Pfizer Inc. (U.S.)
10.3.9. Teva Pharmaceutical Industries Ltd. (Israel)
10.3.10. Sun Pharmaceutical Industries Ltd. (India)
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
